Arrowhead Pharmaceuticals (ARWR) Invested Capital (2010 - 2026)
Arrowhead Pharmaceuticals (ARWR) posted Invested Capital of $687.44 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 9.6% from $760.14 million a year earlier and down 13.9% from the prior quarter.
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Invested Capital (2010 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Arrowhead Pharmaceuticals' Invested Capital came in at $758.3 million, up 29.8% from FY2024.
- In prior fiscal years, Arrowhead Pharmaceuticals' Invested Capital was $584.25 million in FY2024 (+103.5%) and $287.16 million in FY2023.
- The fiscal Q3 2026 figure stands as the lowest quarterly Invested Capital since fiscal Q1 2025.
- On a year-over-year basis, Invested Capital increased in three of the last five quarters, with growth averaging 34.3%.
- According to Business Quant data, Invested Capital for the three prior fiscal quarters was $798.56 million (Q2 2026), $765.81 million (Q1 2026) and $758.3 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 134.01 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 64.89 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 95.89 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 79.44 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.26 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 68.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 38.08 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 148.69 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Arrowhead Pharmaceuticals | 9.24 Bn | 4.02 Bn | - | 687.44 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 687.44 Mn |
| Mar 31, 2026 | 798.56 Mn |
| Dec 31, 2025 | 765.81 Mn |
| Sep 30, 2025 | 758.30 Mn |
| Jun 30, 2025 | 760.14 Mn |
| Mar 31, 2025 | 958.15 Mn |
| Dec 31, 2024 | 465.49 Mn |
| Sep 30, 2024 | 584.25 Mn |
| Sep 30, 2023 | 287.16 Mn |
| Sep 30, 2018 | 97.57 Mn |
| Jun 30, 2018 | 104.14 Mn |
| Mar 31, 2018 | 116.15 Mn |
| Dec 31, 2017 | 72.68 Mn |
| Sep 30, 2017 | 83.40 Mn |
| Jun 30, 2017 | 92.68 Mn |
| Mar 31, 2017 | 96.52 Mn |
| Dec 31, 2016 | 100.44 Mn |
| Sep 30, 2016 | 97.75 Mn |
| Jun 30, 2016 | 62.71 Mn |
| Sep 30, 2014 | 166.04 Mn |
API Access
Arrowhead Pharmaceuticals Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();